|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
EBSCO_ocn965196278 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
161205t20172017nyu ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d EBLCP
|d N$T
|d YDX
|d OCLCF
|d OCL
|d AGLDB
|d IGB
|d CN8ML
|d SNK
|d INTCL
|d MHW
|d BTN
|d AUW
|d OCLCQ
|d VTS
|d OCLCQ
|d D6H
|d G3B
|d S8I
|d S8J
|d S9I
|d STF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 972919444
|a 973054977
|
| 020 |
|
|
|a 9781536101492
|q (electronic bk.)
|
| 020 |
|
|
|a 1536101494
|q (electronic bk.)
|
| 020 |
|
|
|z 9781536101355
|
| 035 |
|
|
|a (OCoLC)965196278
|z (OCoLC)972919444
|z (OCoLC)973054977
|
| 050 |
|
4 |
|a R850
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Advances in medicine and biology.
|n Volume 108 /
|c Leon V. Berhardt, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Science Publishers, Inc. :
|b Nova Biomedical,
|c [2017]
|
| 264 |
|
4 |
|c ©2017
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Preface; Hyperpigmentation: Etiology, Topical Treatments and Effectiveness; Abstract; Introduction; Melanogenesis: Physiologic Aspect; Causes of Hyperpigmentation; Epidermal Melanocytosis; Epidermal Pigmented Lesions; Freckles, Lentigines and Solar Lentigo; Epidermal Acquired Pigmented Disorders; Melasma; Acanthosis Nigricans; Dermal Melanocytosis; Dermal Pigmented Lesions; Nevus of Ota and Nevus of Ito; Hori nevus; Dermal Acquired Pigmented Dermatoses; Periorbital Hyperpigmentation; Erythema Dyschromicum Perstans; Riehl Melanosis; Erythromelanosis Follicularis Faciei.
|
| 505 |
8 |
|
|a Poikiloderma of CivatteInherited Pigmented Disorders; Familial Lentiginosis Syndrome; Peutz-Jeghers Syndrome; Carney Complex; LEOPARD Syndrome; PTEN Hamartoma Tumor Syndromes; Benign Acquired Lentiginosis; Laugier-Hunziker Syndrome; Post-Inflammatory Hyperpigmentation; Drug and Chemical-Induced Hyperpigmentation; Endocrine and Metabolic Disorders; Addison's Disease; Hemochromatosis; Miscellaneous; Treatment of Skin Hyperpigmentation; Depigmenting Therapies with Lightening Topical Agents; Physical Treatments; Novel Terapeutical Proposal; References; Ankylosing Spondylitis: A Review; Abstract.
|
| 505 |
8 |
|
|a 1. Introduction2. Ankylosing Spondylitis; 2.1. Aetiology and Incidence; 2.2. Pathophysiology; 2.3. Diagnosis; 2.3.1. Symptoms; 2.3.2. Laboratory Tests; 2.3.3. Imaging; 2.4. Management of the Disease; Surgery; Pharmacological Treatment; Non-Steroidal Anti-Inflammatory Drugs; Anti-Tumour Necrosis Factor (TNF); Non-Pharmacological Therapy; Physical Therapy; Education; Conclusion; References; Pulmonary and Cutaneous CO2 Emission Monitoring under Anesthesia; Patients' Induced Pluripotent Stem Cells to Model Thiopurine Induced Pancreatitis.
|
| 505 |
8 |
|
|a Prediction of Thiopurine-Induced Pancreatitis: A Possible Application of Patients' Induced Pluripotent Stem CellsPersonalized Medicine as a Tool to Tailor Therapy and to Prevent Adverse Thiopurine Reactions; Adverse Drug Reactions and Drug-Induced Pancreatitis; Thiopurines in the Treatment of IBD and Manifestation of Adverse Drug Reactions as Pancreatitis; Genetic Markers for Thiopurine-Induced Pancreatitis in Inflammatory Bowel Disease Patients; Induced Pluripotent Stem Cells (iPSC): A Ground-Breaking Tool for Personalized Medicine.
|
| 505 |
8 |
|
|a Exocrine Pancreatic Cells from Patients' iPSC as Most Appropriate Cell Subtype to Model TIPThe Molecular Mechanism of TIP Investigated Using Patient Specific iPSC Derived Exocrine Pancreatic Cells; Biotransformation Hypothesis; Innate Immunity Hypothesis; Adaptive Immunity Hypothesis; Caveats of Exocrine Pancreatic Cells Derived from Patients' iPSC as a Model for TIP; The Prevention of TIP Using Patients' iPSC; Conclusion; Acknowledgments; Conflict of Interest; References; Bioluminescence Microscopy in Live Cells: Consideration of Experimental Factors and Practical Recommendations.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed March 2, 2017).
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Medicine
|x Research.
|
| 650 |
|
0 |
|a Biology
|x Research.
|
| 650 |
|
6 |
|a Médecine
|x Recherche.
|
| 650 |
|
6 |
|a Biologie
|x Recherche.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Biology
|x Research
|2 fast
|
| 650 |
|
7 |
|a Medicine
|x Research
|2 fast
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1430781
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4775051
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1430781
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 13150624
|
| 994 |
|
|
|a 92
|b IZTAP
|
